CHAKRAPANI SUBRAMANYAM

Person

SOUTH GLASTONBURY, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Anti-EDB antibodies and antibody-drug conjugates
- Patent number 11,833,216
- Issue date Dec 5, 2023
- Pfizer Inc.
- Andrea Therese Hooper
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional cytotoxic agents containing the CTI pharmacophore
- Patent number 11,365,263
- Issue date Jun 21, 2022
- Pfizer Inc.
- Andreas Maderna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bifunctional cytotoxic agents containing the CTI pharmacophore
- Patent number 10,870,706
- Issue date Dec 22, 2020
- Pfizer Inc.
- Andreas Maderna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional cytotoxic agents
- Patent number 10,391,182
- Issue date Aug 27, 2019
- Pfizer Inc.
- Andreas Maderna
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bifunctional cytotoxic agents
- Patent number 10,086,085
- Issue date Oct 2, 2018
- Pfizer Inc.
- Andreas Maderna
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 10,077,272
- Issue date Sep 18, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,868,744
- Issue date Jan 16, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,856,263
- Issue date Jan 2, 2018
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,850,232
- Issue date Dec 26, 2017
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spliceostatin analogs and methods for their preparation
- Patent number 9,764,040
- Issue date Sep 19, 2017
- Pfizer Inc.
- Chakrapani Subramanyam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegene...
- Patent number 9,751,877
- Issue date Sep 5, 2017
- Pfizer Inc.
- Martin Youngjin Pettersson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,688,698
- Issue date Jun 27, 2017
- Pfizer Inc.
- David Lawrence Firman Gray
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,617,275
- Issue date Apr 11, 2017
- Pfizer Inc.
- Jotham Wadsworth Coe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 1,7-naphthyridines as dopamine D1 ligands
- Patent number 9,540,352
- Issue date Jan 10, 2017
- Pfizer Inc.
- David Lawrence Firman Gray
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,527,843
- Issue date Dec 27, 2016
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spliceostatin analogs and methods for their preparation
- Patent number 9,504,669
- Issue date Nov 29, 2016
- Pfizer Inc.
- Chakrapani Subramanyam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytotoxic peptides and antibody drug conjugates thereof
- Patent number 9,249,186
- Issue date Feb 2, 2016
- Pfizer Inc.
- Matthew David Doroski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegene...
- Patent number 9,193,726
- Issue date Nov 24, 2015
- Pfizer Inc.
- Martin Youngjin Pettersson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spliceostatin analogs and methods for their preparation
- Patent number 9,169,264
- Issue date Oct 27, 2015
- Pfizer Inc.
- Chakrapani Subramanyam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytotoxic peptides and antibody drug conjugates thereof
- Patent number 9,138,486
- Issue date Sep 22, 2015
- Pfizer Inc.
- Matthew David Doroski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 9,133,190
- Issue date Sep 15, 2015
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic pyridinones
- Patent number 9,067,934
- Issue date Jun 30, 2015
- Pfizer Inc.
- Martin Youngjin Pettersson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegene...
- Patent number 8,916,564
- Issue date Dec 23, 2014
- Pfizer Inc.
- Martin Youngjin Pettersson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytotoxic peptides and antibody drug conjugates thereof
- Patent number 8,828,401
- Issue date Sep 9, 2014
- Pfizer Inc.
- Matthew David Doroski
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heteroaromatic compounds and their use as dopamine D1 ligands
- Patent number 8,822,494
- Issue date Sep 2, 2014
- Pfizer Inc.
- Jennifer Elizabeth Davoren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic pyridinones
- Patent number 8,697,673
- Issue date Apr 15, 2014
- Pfizer Inc.
- Martin Youngjin Pettersson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused pyridine compounds as casein kinase inhibitors
- Patent number 8,536,164
- Issue date Sep 17, 2013
- Pfizer Inc.
- Todd W. Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds as casein kinase inhibitors
- Patent number 8,518,944
- Issue date Aug 27, 2013
- Pfizer Inc.
- Chakrapani Subramanyam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzamide inhibitors of the P2X7 receptor
- Patent number 7,553,972
- Issue date Jun 30, 2009
- Pfizer, Inc.
- Mark A. Dombrowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzamide, heteroarylamide and reverse amides
- Patent number 7,235,549
- Issue date Jun 26, 2007
- Pfizer Inc.
- Allen J. Duplantier
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF
- Publication number 20240409573
- Publication date Dec 12, 2024
- Pfizer Inc.
- Omar Khaled Ahmad
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20240261423
- Publication date Aug 8, 2024
- Pfizer Inc.
- Andrea Therese HOOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20240181071
- Publication date Jun 6, 2024
- Pfizer Inc.
- Andrea Therese HOOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20240156977
- Publication date May 16, 2024
- Pfizer Inc.
- Andrea Therese HOOPER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20230241235
- Publication date Aug 3, 2023
- Pfizer Inc.
- Andrea Therese HOOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE
- Publication number 20210061923
- Publication date Mar 4, 2021
- Pfizer Inc.
- Andreas MADERNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CALICHEAMICIN DERATIVES AND ANTIBODY DRUG CONJUGATES THEREOF
- Publication number 20190345186
- Publication date Nov 14, 2019
- Pfizer Inc.
- Omar Khaled Ahmad
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES
- Publication number 20190269791
- Publication date Sep 5, 2019
- Pfizer Inc.
- Andrea Therese HOOPER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION
- Publication number 20180362519
- Publication date Dec 20, 2018
- Pfizer Inc.
- Chakrapani SUBRAMANYAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180346477
- Publication date Dec 6, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL CYTOTOXIC AGENTS
- Publication number 20180339060
- Publication date Nov 29, 2018
- Pfizer Inc.
- Andreas MADERNA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20180200253
- Publication date Jul 19, 2018
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20180072750
- Publication date Mar 15, 2018
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20170165270
- Publication date Jun 15, 2017
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037053
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20170037049
- Publication date Feb 9, 2017
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPLICEOSTATIN ANALOGS AND METHOS FOR THEIR PREPARATION
- Publication number 20170014523
- Publication date Jan 19, 2017
- Pfizer Inc.
- Chakrapani SUBRAMANYAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE
- Publication number 20160271270
- Publication date Sep 22, 2016
- Pfizer Inc.
- Andreas MADERNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS
- Publication number 20160229847
- Publication date Aug 11, 2016
- Pfizer Inc.
- Martin Youngjin Pettersson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20160200711
- Publication date Jul 14, 2016
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPLICEOSTATIN ANALOGS AND METHODS FOR THEIR PREPARATION
- Publication number 20160022626
- Publication date Jan 28, 2016
- Pfizer Inc.
- Chakrapani SUBRAMANYAM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Pyrido[1,2-a]Pryazines And Their Use in the Treatment of Neur...
- Publication number 20160024088
- Publication date Jan 28, 2016
- Pfizer Inc.
- Martin Youngjin Pettersson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150344490
- Publication date Dec 3, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150344474
- Publication date Dec 3, 2015
- Pfizer Inc.
- JENNIFER ELIZABETH DAVOREN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150307522
- Publication date Oct 29, 2015
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS
- Publication number 20150307494
- Publication date Oct 29, 2015
- Pfizer Inc.
- DAVID LAWRENCE FIRMAN GRAY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF
- Publication number 20150307551
- Publication date Oct 29, 2015
- Pfizer Inc.
- Matthew David DOROSKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaromatic Compounds and their Use as Dopamine D1 Ligands
- Publication number 20150291625
- Publication date Oct 15, 2015
- Pfizer Inc.
- JOTHAM WADSWORTH COE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BIFUNCTIONAL CYTOTOXIC AGENTS
- Publication number 20150209445
- Publication date Jul 30, 2015
- Pfizer Inc.
- Andreas MADERNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel Pyrido[1,2-a]Pryazines And Their Use In The Treatment of Neur...
- Publication number 20150072990
- Publication date Mar 12, 2015
- Pfizer Inc.
- Martin Youngjin Pettersson
- C07 - ORGANIC CHEMISTRY

CHAKRAPANI SUBRAMANYAM

Person

Patents Grantslast 30 patents

Anti-EDB antibodies and antibody-drug conjugates

Bifunctional cytotoxic agents containing the CTI pharmacophore

Bifunctional cytotoxic agents containing the CTI pharmacophore

Bifunctional cytotoxic agents

Bifunctional cytotoxic agents

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Spliceostatin analogs and methods for their preparation

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegene...

Heteroaromatic compounds and their use as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Substituted 1,7-naphthyridines as dopamine D1 ligands

Heteroaromatic compounds and their use as dopamine D1 ligands

Spliceostatin analogs and methods for their preparation

Cytotoxic peptides and antibody drug conjugates thereof

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegene...

Spliceostatin analogs and methods for their preparation

Cytotoxic peptides and antibody drug conjugates thereof

Heteroaromatic compounds and their use as dopamine D1 ligands

Bicyclic pyridinones

Substituted pyrido[1,2-a]pyrazines for the treatment of neurodegene...

Cytotoxic peptides and antibody drug conjugates thereof

Heteroaromatic compounds and their use as dopamine D1 ligands

Bicyclic pyridinones

Fused pyridine compounds as casein kinase inhibitors

Compounds as casein kinase inhibitors

Benzamide inhibitors of the P2X7 receptor

Benzamide, heteroarylamide and reverse amides

Patents Applicationslast 30 patents

CALICHEAMICIN DERIVATIVES AND ANTIBODY DRUG CONJUGATES THEREOF

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE

CALICHEAMICIN DERATIVES AND ANTIBODY DRUG CONJUGATES THEREOF

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

BIFUNCTIONAL CYTOTOXIC AGENTS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

SPLICEOSTATIN ANALOGS AND METHOS FOR THEIR PREPARATION

BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE

NOVEL BICYCLIC PYRIDINONES AS GAMMA-SECRETASE MODULATORS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

SPLICEOSTATIN ANALOGS AND METHODS FOR THEIR PREPARATION

Novel Pyrido[1,2-a]Pryazines And Their Use in the Treatment of Neur...

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS

CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF

Heteroaromatic Compounds and their Use as Dopamine D1 Ligands

BIFUNCTIONAL CYTOTOXIC AGENTS

Novel Pyrido[1,2-a]Pryazines And Their Use In The Treatment of Neur...